115PPathological complete response rates following neoadjuvant systemic therapy in 300 patients with early or locally advanced HER2 positive breast cancer: The Royal Marsden experience. (13th May 2019) - Chaabouni, N; Battisti, N M L; True, V; Chopra, N R; Shepherd, S T C; Lee, K; Joshi, R; Kabir, M; Allen, M; Ring, A